Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

5.16
Delayed Data
As of Jul 02
 -0.08 / -1.53%
Today’s Change
5.06
Today|||52-Week Range
11.74
-26.29%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close5.24
Today’s open5.21
Day’s range5.11 - 5.25
Volume91,188
Average volume (3 months)340,063
Market cap$101.8M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-128.57%
Earnings growth (this year)-12.20%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc+0.06+3.85%
JNPJuniper Pharmaceutic...+0.27+2.96%
ATHXAthersys Inc+0.01+0.83%
ATNMActinium Pharmaceuti...-0.08-2.97%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$0.00
Annual profit (last year)-$22.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers